Charles Albright - Net Worth and Insider Trading

Charles Albright Net Worth

The estimated net worth of Charles Albright is at least $77,710 dollars as of 2024-11-10. Charles Albright is the EVP/Chief Scientific Officer of Editas Medicine Inc and owns about 24,907 shares of Editas Medicine Inc (EDIT) stock worth over $77,710. Details can be seen in Charles Albright's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles Albright has not made any transactions after 2020-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Charles Albright

To

Charles Albright Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Charles Albright owns 1 companies in total, including Editas Medicine Inc (EDIT) .

Click here to see the complete history of Charles Albright’s form 4 insider trades.

Insider Ownership Summary of Charles Albright

Ticker Comapny Transaction Date Type of Owner
EDIT Editas Medicine Inc 2020-12-15 Chief Scientific Officer

Charles Albright Latest Holdings Summary

Charles Albright currently owns a total of 1 stock. Charles Albright owns 24,907 shares of Editas Medicine Inc (EDIT) as of December 15, 2020, with a value of $77,710.

Latest Holdings of Charles Albright

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EDIT Editas Medicine Inc 2020-12-15 24,907 3.12 77,710

Holding Weightings of Charles Albright


Charles Albright Form 4 Trading Tracker

According to the SEC Form 4 filings, Charles Albright has made a total of 11 transactions in Editas Medicine Inc (EDIT) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Editas Medicine Inc is the sale of 10,000 shares on December 15, 2020, which brought Charles Albright around $632,200.

Insider Trading History of Charles Albright

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Charles Albright Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Charles Albright Ownership Network

Ownership Network List of Charles Albright

No Data

Ownership Network Relation of Charles Albright

Insider Network Chart

Charles Albright Owned Company Details

What does Editas Medicine Inc do?

Who are the key executives at Editas Medicine Inc?

Charles Albright is the Chief Scientific Officer of Editas Medicine Inc. Other key executives at Editas Medicine Inc include SVP & CHIEF MEDICAL OFFICER Baisong Mei , director & CEO Gilmore Neil O'neill , and EVP & CHIEF SCIENTIFIC OFFICER Linda Burkly .

Editas Medicine Inc (EDIT) Insider Trades Summary

Over the past 18 months, Charles Albright made no insider transaction in Editas Medicine Inc (EDIT). Other recent insider transactions involving Editas Medicine Inc (EDIT) include a net sale of 2,656 shares made by Bruce Eaton , a net sale of 32,292 shares made by Baisong Mei , and a net sale of 98,056 shares made by Gilmore Neil O'neill .

In summary, during the past 3 months, insiders sold 2,073 shares of Editas Medicine Inc (EDIT) in total and bought 0 shares, with a net sale of 2,073 shares. During the past 18 months, 168,176 shares of Editas Medicine Inc (EDIT) were sold and 45,000 shares were bought by its insiders, resulting in a net sale of 123,176 shares.

Editas Medicine Inc (EDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Editas Medicine Inc Insider Transactions

No Available Data

Charles Albright Mailing Address

Above is the net worth, insider trading, and ownership report for Charles Albright. You might contact Charles Albright via mailing address: 87 Mill Road, Madison Ct 06443.